Back
Tarsus Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
TARS
Tarsus Pharmaceuticals
Last Price:
$43.24
Seasonality Move:
8.01%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing slight selling pressure.
Tarsus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.24 | Buy |
| 20-day SMA: | 40.76 | Buy |
| 50-day SMA: | 42.14 | Buy |
| 200-day SMA: | 46.14 | Sell |
| 8-day EMA: | 37.24 | Buy |
| 20-day EMA: | 24.5 | Buy |
| 50-day EMA: | 12.44 | Buy |
| 200-day EMA: | 3.54 | Buy |
Tarsus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.59 | Buy |
| Relative Strength Index (14 RSI): | 57.7 | Buy |
| Chaikin Money Flow: | -577356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.93 - 41.57) | Buy |
| Bollinger Bands (100): | (41.29 - 48.71) | Sell |
Tarsus Pharmaceuticals Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Tarsus Pharmaceuticals Stock
Is Tarsus Pharmaceuticals Stock a Buy?
-
Tarsus Pharmaceuticals share price is 43.25 while TARS 8-day simple moving average is 41.24, which is a Buy signal.
-
The stock price of TARS is 43.25 while Tarsus Pharmaceuticals 20-day SMA is 40.76, which makes it a Buy.
-
Tarsus Pharmaceuticals 50-day simple moving average is 42.14 while TARS share price is 43.25, making it a Buy technically.
-
TARS stock price is 43.25 and Tarsus Pharmaceuticals 200-day simple moving average is 46.14, creating a Sell signal.
TARS Technical Analysis vs Fundamental Analysis
Sell
30
Tarsus Pharmaceuticals (TARS)
is a Sell
Is Tarsus Pharmaceuticals a Buy or a Sell?
-
Tarsus Pharmaceuticals stock is rated a SellThe current Tarsus Pharmaceuticals [TARS] share price is $43.25. The Score for TARS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Tarsus Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
43.25
Share Volume:
1.3M
Tarsus Pharmaceuticals 52-Week Range
52-Week High:
57.28
52-Week Low:
20.08
Sell
30
Tarsus Pharmaceuticals (TARS)
is a Sell
Tarsus Pharmaceuticals Share Price Forecast
-
What is the Tarsus Pharmaceuticals stock price today?The Tarsus Pharmaceuticals stock price is 43.25 USD today.
-
Will TARS stock go up or go down?Tarsus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Tarsus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tarsus Pharmaceuticals is overvalued.
Is Tarsus Pharmaceuticals Stock a Buy?
-
Tarsus Pharmaceuticals share price is 43.25 while TARS 8-day exponential moving average is 37.24, which is a Buy signal.
-
The stock price of TARS is 43.25 while Tarsus Pharmaceuticals 20-day EMA is 24.50, which makes it a Buy.
-
Tarsus Pharmaceuticals 50-day exponential moving average is 12.44 while TARS share price is 43.25, making it a Buy technically.
-
TARS stock price is 43.25 and Tarsus Pharmaceuticals 200-day simple moving average is 3.54, creating a Buy signal.
Fundamental Analysis of Tarsus Pharmaceuticals
Is Tarsus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.51 per share, an increase this year of $2.02 per share, and an increase next year of $1.34 per share.
Technical Analysis of Tarsus Pharmaceuticals
Should I short Tarsus Pharmaceuticals stock?
-
TARS Moving Average Covergence Divergence (MACD) indicator is 11.59, suggesting Tarsus Pharmaceuticals is a Buy
-
Tarsus Pharmaceuticals Relative Strength Index (RSI) is 57.7, which suggest Tarsus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Tarsus Pharmaceuticals is (39.93 - 41.57), which suggest Tarsus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Tarsus Pharmaceuticals is (41.29 - 48.71), which suggest Tarsus Pharmaceuticals is a Sell
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.